Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Entera Bio Ltd (ENTX)
NASDAQ:ENTX
Holding ENTX?
Track your performance easily
ENTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.52 - $3.35
Previous Close$1.67
Volume65.03K
Average Volume (3M)31.48K
Market Cap
$61.88M
Enterprise Value$54.90M
Total Cash (Recent Filing)$6.92M
Total Debt (Recent Filing)$309.00K
Price to Earnings (P/E)―
Beta-0.07
Next Earnings
Mar 27, 2025EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding36,832,220
10 Day Avg. Volume25,641
30 Day Avg. Volume31,480
Standard Deviation0.29
R-Squared0.08
Alpha0.00883
Financial Highlights & Ratios
Price to Book (P/B)7.26
Price to Sales (P/S)1083.36
Price to Cash Flow (P/CF)-11.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue554.58
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.03
Forecast
1Y Price Target
$10.00Price Target Upside495.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Entera Bio News
PremiumCompany Announcements
Entera Bio Highlights Q3 2024 Financials and FDA Anticipation
PremiumCompany Announcements
Entera Bio Clarifies Non-Binding Information Disclosure
PremiumCompany Announcements
Entera Bio Releases Crucial Financial Information UpdateOwnership Overview
2.55% Insiders
0.05% Mutual Funds
0.16% Other Institutional Investors
97.24% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ENTX FAQ
What was Entera Bio Ltd’s price range in the past 12 months?
Entera Bio Ltd lowest stock price was $0.52 and its highest was $3.35 in the past 12 months.
What is Entera Bio Ltd’s market cap?
Currently, no data Available
When is Entera Bio Ltd’s upcoming earnings report date?
Entera Bio Ltd’s upcoming earnings report date is Mar 27, 2025 which is in 133 days.
How were Entera Bio Ltd’s earnings last quarter?
Entera Bio Ltd released its earnings results on Nov 08, 2024. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of -$0.05 by -$0.03.
Is Entera Bio Ltd overvalued?
According to Wall Street analysts Entera Bio Ltd’s price is currently Undervalued.
Does Entera Bio Ltd pay dividends?
Entera Bio Ltd does not currently pay dividends.
What is Entera Bio Ltd’s EPS estimate?
Entera Bio Ltd’s EPS estimate is -$0.08.
How many shares outstanding does Entera Bio Ltd have?
Entera Bio Ltd has 36,832,220 shares outstanding.
What happened to Entera Bio Ltd’s price movement after its last earnings report?
Entera Bio Ltd reported an EPS of -$0.08 in its last earnings report, missing expectations of -$0.05. Following the earnings report the stock price went down -1.163%.
Which hedge fund is a major shareholder of Entera Bio Ltd?
Among the largest hedge funds holding Entera Bio Ltd’s share is RA Capital Management. It holds Entera Bio Ltd’s shares valued at N/A.
---
Entera Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (495.24% Upside)
$10.00 (495.24% Upside)
Blogger Sentiment
Bullish
ENTX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 296.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.1%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
138.57%
12-Months-Change
Fundamentals
Return on Equity
-144.67%
Trailing 12-Months
Asset Growth
-9.62%
Trailing 12-Months
Company Description
Entera Bio Ltd
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. It develops an oral formulation of parathyroid hormone. The company was founded on June 1, 2010 and is headquartered in Jerusalem, Israel.
---
ENTX Stock 12 Month Forecast
Average Price Target
$10.00
▲(495.24% Upside)
Technical Analysis
Best Analysts Covering ENTX
1 Year
1 Year Success Rate
7/13 ratings generated profit
1 Year Average Return
+55.24%
reiterated a buy rating 4 days ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of +55.24% per trade.
---